12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Friday's intraday session, several healthcare stocks experienced significant movements. Avalo Therapeutics led the gainers with a 364.8% increase, while Tonix Pharmaceuticals headed the losers with a 45.4% decrease. Other notable movers include Nexalin Technology and Biodexa Pharmaceuticals with substantial gains, and Kodiak Sciences and ENDRA Life Sciences among the losers, with their recent Q4 earnings reports influencing their stock prices.
March 29, 2024 | 4:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Avalo Therapeutics shares surged 364.8% to $22.08, with a market cap of $17.6 million.
The substantial increase in Avalo Therapeutics' stock price could attract more investors in the short term, potentially maintaining or increasing the stock's upward momentum.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Kodiak Sciences stock decreased by 29.6% to $5.25 after the Q4 earnings report, with a market cap of $275.2 million.
The negative reaction to Kodiak Sciences' Q4 earnings report suggests that the results did not meet investor expectations, likely causing the stock price to drop in the short term.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
ENDRA Life Sciences shares decreased by 28.84% to $0.58 after the Q4 earnings report, with a market cap of $6.4 million.
The decline in ENDRA Life Sciences' stock price post-Q4 earnings indicates that the financial results likely disappointed investors, affecting the stock negatively in the short term.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
Tonix Pharmaceuticals stock decreased by 45.4% to $0.18, with a market cap of $10.4 million.
The significant drop in Tonix Pharmaceuticals' stock price could lead to a negative sentiment among investors, potentially causing further short-term declines.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100